Pavelka R, Salzer H, Reinold E
Zentralbl Gynakol. 1978;100(16):1025-9.
The effectiveness of a routinely performed puerperal rubella vaccination was tested. Additional a possible adverse influence of simultaneously administered anti-D immunoglobulin on the effectiveness of the rubella vaccination was examined. Rubella antibody titers (HHT) in pregnant women were determined; after delivery puerperal women with titers of less or equal 1:16 were selected for rubella vaccination. 2 1/2 to 3 months later rubella antibody titers were done again. 15% of 130 vaccinated women did not show a conversion of the former negative titer or a low titer of 1:8 remained. Also reductions of the antibody titers were seen. When simultaneously rubella vaccination and anti-D immunoglobulin was administered only in 1 case out of 27 patients a negative titer remained after vaccination. The used anti-D immunoglobulin contained rubella antibodies of a titer 1:256 to 1:512; according to experimental studies, this concentration should not have any influence to the immunologic response of rubella vaccination. Our practic results could not confirm the reservations concerning simultaneous rubella vaccination and anti-D prophylaxis.
对常规进行的产后风疹疫苗接种的有效性进行了测试。此外,还研究了同时给予抗-D免疫球蛋白对风疹疫苗接种效果可能产生的不良影响。测定了孕妇的风疹抗体滴度(HHT);分娩后,选择风疹抗体滴度小于或等于1:16的产后妇女进行风疹疫苗接种。2个半月至3个月后再次检测风疹抗体滴度。130名接种疫苗的妇女中有15%未出现先前阴性滴度的转化,或仍保持1:8的低滴度。也观察到了抗体滴度的降低。当同时接种风疹疫苗和抗-D免疫球蛋白时,27名患者中只有1例在接种后仍为阴性滴度。所使用的抗-D免疫球蛋白含有滴度为1:256至1:512的风疹抗体;根据实验研究,该浓度对风疹疫苗接种的免疫反应不应有任何影响。我们的实际结果无法证实关于同时进行风疹疫苗接种和抗-D预防的疑虑。